Cancer Family
Malignant Thoracic Neoplasm
CI-CAN-00000256Explore in graph →
2,775 active trials51 approved drugs626 evidence items
- NCIt
- C3576
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000256Explore in graph →
Clinical trials
11,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,528)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06896890 | Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer | recruiting | Phase 1 / Phase 2 | 32 | Inhatarget TherapeuticsINDUSTRY | 3 | Mar 26, 2025 | clinicaltrials |
| NCT03978377 | Cardiopulmonary Toxicity of Thoracic Radiotherapy(CLARIFY) | recruiting | — | 320 | University Medical Center GroningenOTHER | 3 | Mar 25, 2025 |
| clinicaltrials |
| NCT06891183 | Percutaneous Thermal Ablation in Lung Tumors(Radiofrequency) | recruiting | N/A | 50 | Assiut UniversityOTHER | 1 | Mar 24, 2025 | clinicaltrials |
| NCT06886672 | Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS(MAGNETS) | recruiting | — | 60 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05636969 | Multimodal Prehabilitation in Patients with Lung Cancer Undergoing Neoadjuvant Therapy | recruiting | N/A | 60 | Hospital Clinic of BarcelonaOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06377124 | A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients | recruiting | N/A | 320 | The University of Hong KongOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06717243 | Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)(STRATUS) | recruiting | — | 111 | Oncology Center of Biochemical Education And ResearchOTHER | 2 | Mar 19, 2025 | clinicaltrials |
| NCT06663098 | Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).(CARRY-ON) | recruiting | Phase 2 | 142 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT04510129 | A Multicenter Cancer Biospecimen Collection Study | recruiting | — | 1,650 | Cofactor Genomics, Inc.INDUSTRY | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06617416 | A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC | recruiting | Phase 3 | 560 | AkesoINDUSTRY | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06730295 | Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer | recruiting | Phase 2 | 52 | Sun Yat-sen UniversityOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06869239 | Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy | recruiting | — | 65 | Peking University Cancer Hospital & InstituteOTHER | 1 | Mar 11, 2025 | clinicaltrials |
| NCT03987633 | EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality(EMPOWER) | recruiting | — | 200,000 | Future Genetics LimitedOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT05463913 | Lung Nodule Detection Using Ultra-long FOV PET/CT | recruiting | Phase 4 | 20 | University Medical Center GroningenOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06863506 | Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC | recruiting | Phase 2 | 78 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06643000 | Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis | recruiting | N/A | 60 | Henan Cancer HospitalOTHER_GOV | 1 | Mar 6, 2025 | clinicaltrials |
| NCT04777084 | The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined with Lenvatinib in NSCLC. | recruiting | Phase 2 | 120 | Hunan Province Tumor HospitalOTHER | 1 | Mar 5, 2025 | clinicaltrials |
| NCT06069570 | Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases | recruiting | Phase 1 | 48 | Kiromic BioPharma Inc.INDUSTRY | 1 | Mar 5, 2025 | clinicaltrials |
| NCT06853678 | Second-line Immunotherapy for ES-SCLC | recruiting | N/A | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Mar 3, 2025 | clinicaltrials |
| NCT04147078 | Personalized DC Vaccine for Postoperative Cancer | recruiting | Phase 1 | 80 | Sichuan UniversityOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06849518 | Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer | recruiting | N/A | 30 | Ballad HealthOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06692972 | The Regression Pattern of Primary Lesions in Lung Cancer After Definitive Radiotherapy | recruiting | — | 500 | China-Japan Friendship HospitalOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06849167 | Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC | recruiting | Phase 2 | 63 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06846762 | DREAM Study: DNA/RNA-NGS Co-Testing in Driver-Negative, Treatment-Resistant NSCLC | recruiting | — | 508 | Baohui HanOTHER | 1 | Feb 26, 2025 | clinicaltrials |
| NCT05477979 | The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG) | recruiting | — | 750 | Second Xiangya Hospital of Central South UniversityOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT06843707 | Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics. | recruiting | — | 2,500 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT06484816 | TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies | recruiting | Phase 1 | 90 | Shenzhen TargetRx Co., Ltd.INDUSTRY | 1 | Feb 24, 2025 | clinicaltrials |
| NCT05281406 | Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG) | recruiting | Phase 2 | 50 | Goethe UniversityOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06771960 | Association Between RVT and Prognosis After Neoadjuvant Targeted Therapy in EGFR NSCLC | recruiting | — | 120 | Guangdong Provincial People's HospitalOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06833632 | Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer | recruiting | — | 100 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients(CRISP) | recruiting | — | 12,400 | AIO-Studien-gGmbHOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06272864 | BostonGene and Exigent Genomic INsight Study(BEGIN) | recruiting | — | 400 | BostonGeneINDUSTRY | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06458894 | Research on Building and Application of Internet-based Home Pre-rehabilitation Model for Lung Surgery Patients. | recruiting | N/A | 100 | The Fourth Affiliated Hospital of Zhejiang University School of MedicineOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT03647098 | Survival Outcomes of Lung Cancer(Soul) | recruiting | — | 20,000 | Hunan Province Tumor HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT04616209 | Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients | recruiting | Phase 1 / Phase 2 | 24 | Precision Biotech Taiwan Corp.INDUSTRY | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05104515 | First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine | recruiting | Phase 1 | 36 | Oxford Vacmedix UK Ltd.INDUSTRY | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05669430 | A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies | recruiting | Phase 1 / Phase 2 | 365 | GV20 TherapeuticsINDUSTRY | 1 | Feb 13, 2025 | clinicaltrials |
| NCT05257967 | CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease | recruiting | N/A | 10 | British Columbia Cancer AgencyOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06613009 | Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer | recruiting | Phase 1 | 190 | Innovent Biologics (Suzhou) Co. Ltd.INDUSTRY | 2 | Feb 11, 2025 | clinicaltrials |
| NCT06714708 | Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC | recruiting | Phase 2 | 86 | Anhui Provincial Cancer HospitalOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06818149 | Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer | recruiting | — | 50 | Shanghai Chest HospitalOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06464861 | Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma(CD19-CARNK/T) | recruiting | Phase 1 | 52 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT04886401 | Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLC(PREDICTION) | recruiting | — | 50 | University Hospital, BrestOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06082492 | The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients(NVALT31-PET) | recruiting | N/A | 690 | Radboud University Medical CenterOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT06807307 | Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential(KEAPnes) | recruiting | — | 256 | Regina Elena Cancer InstituteOTHER | 1 | Feb 4, 2025 | clinicaltrials |
| NCT03740503 | Genomic Investigation of Unusual Responders(GENIUS) | recruiting | — | 100 | University Health Network, TorontoOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT03382158 | International PPB/DICER1 Registry | recruiting | — | 3,400 | Children's Hospitals and Clinics of MinnesotaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT05819346 | Digital Lifestyle Intervention for Lung Cancer Survivors(QUALUCA) | recruiting | N/A | 88 | Kai-Uwe Schmitt, PhD, MEng, ICIDOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06341933 | Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection | recruiting | — | 100 | Atatürk Chest Diseases and Chest Surgery Training and Research HospitalOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06781450 | Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context(PRIMICI) | recruiting | — | 50 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Mar 26, 2025source: clinicaltrials